IP Library Granted Patent US 12,691,104
Granted Patent B2
US 12,691,104 · App. 18/250,874 · Granted Jul 28, 2026

Compositions containing nicotinamide and vitamin B6 and methods of using such compositions for treating sarcopenia and frailty

Inventors: Pascal Stuelsatz (Crissier, CH); Jerome Feige (Crissier, CH); Joris Michaud (Lausanne, CH); Eugenia Linda Migliavacca (Lausanne, CH)
Assignee: Societe des Produits Nestle S.A.
A61K31/4415A61K31/455A61P21/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,691,104
App. No.
18/250,874
Granted
Jul 28, 2026
Kind
B2
Abstract

A composition contains Nicotinamide and pyridoxine. The composition may be an oral nutritional composition, for example a nutritional supplement, an oral nutritional supplement, a food product, a food for special medical purpose (FSMP). The composition can be administered to an individual in need thereof orally or intravenously for preventing and/or treating sarcopenia, physical frailty, a loss of and/or improving skeletal muscle mass, lean muscle mass, skeletal muscle strength and/or skeletal muscle function.

Claims (16)

1 . A method for treating sarcopenia and/or physical frailty, and/or improving skeletal muscle mass, skeletal muscle lean mass, skeletal muscle strength and/or skeletal muscle function in an individual in need thereof, the method comprising administering to the individual a therapeutically effective amount of a composition comprising a combination of Vitamin B6 and Nicotinamide in a weight ratio of from about 1:80 to about 1:20.

2 . The method according to claim 1 , wherein the Vitamin B6 is administered in an amount of 1.0-600 mg vitamin B6 per day.

3 . The method according to claim 1 , wherein the Nicotinamide is administered in an amount of about 1 mg/day to about 3000 mg/day.

4 . The method according to claim 1 , wherein the Vitamin B6 is administered in an amount of 10-20.0 mg vitamin B6 per day, and the Nicotinamide is administered in an amount of about 500 mg to about 1000 mg Nicotinamide per day.

5 . The method according to claim 1 , wherein the Vitamin B6: Nicotinamide are present in a weight ratio of from about 1:100-60 to about 1:930.

6 . The method according to claim 1 , wherein the Vitamin B6: Nicotinamide are present in a weight ratio of from about 1:45 to about 1:30.

7 . The method according to claim 1 , wherein the composition is in a form selected from the group consisting of an oral nutritional composition, a nutritional supplement, an oral nutritional supplement, a medical food, a food supplement, a food product, and a food for special medical purpose (FSMP).

8 . The method according to claim 1 , wherein the composition is in a form selected from the group consisting of a solid powder, a powdered stick, a capsule and a solution.

9 . The method according to claim 1 , wherein the individual has sarcopenia or is at risk thereof, and the administering of the therapeutically effective amount of the composition restores and/or corrects deficiencies of nutrients in the individual.

10 . The method according to claim 1 , wherein the individual is selected from the group consisting of an aging subject; an elderly subject; a subject with muscle fatigue or muscle weakness; a subject with impaired mobility; a frail subject; a pre-frail subject; a sarcopenic subject; and a subject recovering from pre-frailty, frailty, sarcopenia and impaired mobility.

11 . The method according to claim 1 , wherein the composition is a food product further comprising a component selected from the group consisting of protein, carbohydrate, fat and mixtures thereof.

12 . The method according to claim 1 , wherein the administering of the therapeutically effective amount of the composition treats sarcopenia in the individual.

13 . The method according to claim 1 , wherein the administering of the therapeutically effective amount of the composition treats physical frailty in the individual.

14 . The method according to claim 1 , the administering of the therapeutically effective amount of the composition improves skeletal muscle mass, skeletal muscle lean mass, skeletal muscle strength and/or skeletal muscle function in the individual.

15 . The method according to claim 1 , wherein the Vitamin B6 is administered in an amount of 10-20.0 mg vitamin B6 per day.

16 . The method according to claim 1 , wherein the Nicotinamide is administered in an amount of about 500 mg to about 1000 mg Nicotinamide per day.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 4, 2026
From: STUELSATZ, PASCAL; FEIGE, JEROME; MICHAUD, JORIS; MIGLIAVACCA, EUGENIA
To: SOCIETE DES PRODUITS NESTLE S.A.
Reel/Frame 073968/0133 →
Priority Claims (1)
EP 20204865 · Oct 30, 2020 · regional
Continuity (1)
Related Publication 20230390262A1 · Dec 7, 2023
References Cited (22)
US 20120288588A1 · Barron · 2012 [cited by applicant]
US 20230390263A1 · Stuelsatz · 2023 [cited by examiner]
US 20230390264A1 · Stuelsatz · 2023 [cited by examiner]
US 20230398104A1 · Stuelsatz · 2023 [cited by examiner]
US 20250186418A1 · Stuelsatz · 2025 [cited by examiner]
AT 513274 · 2014 [cited by applicant]
CN 101669938A · 2010 [cited by applicant]
CN 102688201A · 2012 [cited by applicant]
CN 107114800 · 2017 [cited by applicant]
CN 109077302A · 2018 [cited by applicant]
CN 109562104A · 2019 [cited by applicant]
CN 109588709 · 2019 [cited by applicant]
JP 2006503896A · 2006 [cited by applicant]
JP 2023523556A · 2023 [cited by applicant]
WO 2005102301 · 2005 [cited by applicant]
WO 2013056048 · 2013 [cited by applicant]
WO 2018221526A1 · 2018 [cited by applicant]
WO 2021004919 · 2021 [cited by applicant]
Guo et al. “Nicotinamide protects against skeletal muscle atrophy in streptozotocin-induced diabetic mice” Archives of Physiology and Biochemistry, 2019, vol. 125, No. 5, pp. 470-477. [cited by applicant]
Suidasari et al. “Dietary vitamin B6 modulates the gene expression of myokines, Nrf2-related factors, myogenin and HSP60 in the skeletal muscle of rats” Experimental and Therapeutic Medicine, 2017, vol. 14, pp. 3239-324… [cited by applicant]
Japanese Office Action for Appl No. 2023-518434 dated Aug. 12, 2025, 6 pages. [cited by applicant]
Chinese Office Action for Appl No. 202180061952.2 dated Dec. 19, 2025, 7 pages. [cited by applicant]